Efficacy of first-line systemic therapy for left-sided primary metastatic colon cancer: a single-centre retrospective cohort analysis of 186 patients

被引：0
|
作者：
Prejac, J. [1 ]
Kekez, D. [2 ]
Belev, B. [3 ]
Plestina, S. [3 ]
机构：
[1] Univ Zagreb, Univ Hosp Ctr Zagreb, Sch Dent Med, Zagreb, Croatia
[2] Univ Hosp Ctr Zagreb, Zagreb, Croatia
[3] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Zagreb, Croatia
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 226
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Retrospective Analysis of nab-Paclitaxel as First-Line Therapy for Metastatic Breast Cancer Patients With Poor Prognostic Factors
    O'Shaughnessy, J.
    Gradishar, W.
    Bhar, P.
    Iglesias, J.
    CANCER RESEARCH, 2012, 72
  • [32] Network Meta-analysis of First-Line Systemic Treatment for Patients With Metastatic Colorectal Cancer
    Xu, Shan
    Sak, Ali
    Erol, Yasin Bahadir
    CANCER CONTROL, 2021, 28
  • [33] A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF PANITUMUMAB WITH CHEMOTHERAPY IN THE FIRST-LINE TREATMENT OF PATIENTS WITH WILD-TYPE RAS METASTATIC COLORECTAL CANCER (MCRC) WITH LEFT-SIDED TUMORS
    Zhou, A.
    Cameron, C.
    Mak, D.
    VALUE IN HEALTH, 2018, 21 : S18 - S18
  • [34] Efficacy of first-line systemic treatment in correlation with BRAF V600E and different KRAS mutations in metastatic colorectal cancer - a single institution retrospective analysis
    Rebersek, Martina
    Boc, Marko
    Cerkovnik, Petra
    Benedik, Jernej
    Hlebanja, Zvezdana
    Volk, Neva
    Novakovic, Srdjan
    Ocvirk, Janja
    RADIOLOGY AND ONCOLOGY, 2011, 45 (04) : 285 - 291
  • [35] De-escalation of radiation therapy after primary systemic therapy in non-metastatic breast cancer: patterns of recurrence from a real-world single-centre cohort of patients
    Banini, M.
    Valzano, M.
    Becherini, C.
    Visani, L.
    Scoccimarro, E.
    Salvestrini, V.
    Lorenzetti, V.
    Frosini, G.
    Peruzzi, A.
    Orzalesi, L.
    Nori, J.
    Bianchi, S.
    Livi, L.
    Meattini, I.
    BREAST, 2023, 68 : S55 - S55
  • [36] Bevacizumab Efficacy Is Influenced by Primary Tumor Resection in First-Line Treatment of Metastatic Colorectal Cancer in a Retrospective Multicenter Study
    Cabart, Mathilde
    Frenel, Jean-Sebastien
    Campion, Loic
    Ramee, Jean-Francois
    Dupuis, Olivier
    Senellart, Helene
    Douillard, Jean-Yves
    Bennouna, Jaafar
    CLINICAL COLORECTAL CANCER, 2016, 15 (04) : E165 - E174
  • [37] Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study
    Piscopo, Leandra
    Volpe, Fabio
    Nappi, Carmela
    Zampella, Emilia
    Manganelli, Mariarosaria
    Matrisciano, Francesca
    Totaro, Pasquale
    Pace, Leonardo
    Maurea, Simone
    Cuocolo, Alberto
    Klain, Michele
    CURRENT ONCOLOGY, 2023, 30 (01) : 37 - 44
  • [38] Safety of first-line systemic therapy in patients with metastatic colorectal cancer: a network meta-analysis of randomized controlled trials
    Zhan, Yanrong
    Cheng, Xianwen
    Mei, Pingping
    Tan, Shufa
    Feng, Wenzhe
    Jiang, Hua
    BMC CANCER, 2024, 24 (01)
  • [39] Outcomes of metastatic gastroesophageal cancer patients treated with third line therapy: a 5-year retrospective analysis at a single centre
    Yick, C. Lam Justina
    Ng, C.
    Cheng, E. Ee Samuel
    Su, P. Choo
    Yew, K. Ong Simon
    Han, C. Toh
    Wen, H. Koo
    Bee, H. Tan Iain
    Chee, K. Tham
    Tai, D.
    Tze, H. Teo Patrick
    ANNALS OF ONCOLOGY, 2016, 27 : 50 - 50
  • [40] Nonoperative management of the primary tumor in patients with unresectable stage IV colon cancer treated with systemic chemotherapy: Higher complication rates for left-sided colon tumors
    Verheij, Floris S.
    Yuval, Jonathan B.
    Kok, Niels F. M.
    Lin, Sabrina T.
    Qin, Li-Xuan
    Omer, Dana M.
    Thompson, Hannah M.
    Wei, Iris H.
    Widmar, Maria
    Pappou, Emmanouil P.
    Weiser, Martin R.
    Nash, Garrett M.
    Smith, J. Joshua
    Paty, Philip B.
    Beets, Geerard L.
    Garcia-Aguilar, Julio
    EJSO, 2024, 50 (01):
12345